Skip to content

GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments

Geo Smoking Study and Neural and Geospatial Examination of Smokers' Exposure to Retail Environments

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04279483
Enrollment
343
Registered
2020-02-21
Start date
2019-12-17
Completion date
2024-06-10
Last updated
2025-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking, Cigarette, Smoking, Tobacco

Keywords

smoking, smoker, tobacco, cigarette, cigarettes, Philadelphia, healthy

Brief summary

The purpose of the study is to learn more about the relationships between the brain, behavior, and natural daily exposure to particular environments, including the places where smokers regularly spend time and specific retail outlets.

Detailed description

Individual participation in this study will take place over a period of approximately 2 months. During (approximately) 6 weeks of the active study period, the participant will be asked to share their geolocation information, complete either (a) 3 online sessions (for all participants in 850796) and an optional fMRI scan (for a subset of protocol 850796) or (b) 3 in-person visits (2 of which involve getting fMRI brain scans, for protocol 822815), and complete short surveys and repeated tasks (e.g., responding to Ecological Momentary Assessment \[EMA\], using study-provided funds to make small purchases from a specified retail environment) in the weeks between visits.

Interventions

BEHAVIORALTobacco retailer

Assigned to make a small (\ $3.00) purchase from a tobacco retail store(s) using a study-provided debit card during each retail environment visit

BEHAVIORALNon-tobacco retailer

Assigned to make a small (\ $3.00) purchase from a store that does not sell tobacco (non-tobacco retailer) using a study-provided debit card during each retail environment visit.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
New York University
CollaboratorOTHER
Stanford University
CollaboratorOTHER
Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Masking description

Investigator will not know the condition assignment of individual participants unless reassessment is triggered by the stopping rule.

Intervention model description

Random assignment of retail environment (tobacco retailer, non-tobacco retailer, control \[no store\]) to visit 5 times per week during the 4-week intervention period

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Be between the ages of 21-65 * Smoke at least 5 cigarettes a day for the past 6 months * Own an iPhone or Android smartphone that can be used on a daily basis * Plan to be in PA, DE, or NJ (for the remote cohort) or the Philadelphia metropolitan area (for the fMRI cohort) for the next 3 months, with the exception of short periods of absence (no longer than 3 consecutive days and no more than 10 days in total) * Read and speak English fluently * Fully vaccinated against COVID-19 Smoking

Exclusion criteria

* Current enrollment or plans to enroll in a smoking cessation program in the next 3 months * Plan to use nicotine substitutes or smoking cessation treatments in the next 3 months * Urine cotinine test at Session 1 indicates a non-smoker level of cotinine General

Design outcomes

Primary

MeasureTime frameDescription
Self-reported Cigarette Craving During the Experimental Manipulation Period4-week experimental manipulation periodParticipants were asked 4 times per day, for the 28 days of the intervention period, to rate their level of craving for a cigarette. They responded to the question Right now, how much do you want to smoke a cigarette? using a 100-point scale from 0 (not at all) to 100 (extremely). Craving ratings were first averaged within each day, for each participant; then were averaged across the intervention period days for each participant; and finally averaged across participants in each group.
Self-reported Number of Cigarettes Smoked Per Day During the Experimental Manipulation Period4-week experimental manipulation periodParticipants were asked 2 times per day, for the 28 days of the intervention period, to respond to the question, Within \[timeframe\], how many cigarettes did you smoke?. We calculated a daily sum for each individual, imputing missing counts from the average of that individual's prior reports (missing values for the first daily survey were imputed from the average of that participant's first daily survey answers; and vice versa for the second survey). We averaged the daily counts for each participant, and then averaged across participants.
Brain Activity (Measured by Functional Magnetic Resonance Imaging) in a Priori Regions of Interest, in Response to Standardized Smoking vs Nonsmoking Cues.[Time Frame: For 822815, fMRI scan 1 (at least 2 weeks after initial enrollment); for 850796, fMRI scan 1 (at least 6 weeks after initial enrollment)]]In key neural cue reactivity regions (based on prior work), we extracted estimates of neural activity during exposure to standardized smoking cues (e.g., photographs of a cigarette pack) and during exposure to standardized nonsmoking cues (approximately compositionally matched, e.g., a pack of pencils). We used SPM12 to create first-level (within-subject) linear regression models to estimate BOLD (blood oxygenation level dependent) activity at each voxel across all repetitions of each task condition, within each subject; and to create contrast estimates comparing task conditions. We used nilearn tools to average task condition contrast estimates across voxels within the regions of interest for each participant. The data values below reflect this contrast estimate - the difference in neural activity as percent change in BOLD signal between the standardized smoking cues condition and the standardized nonsmoking cues condition.
Brain Activity (Measured by fMRI), in a Priori Regions of Interest, in Response to Retail Smoking vs Nonsmoking Cues[Time Frame: For 822815, fMRI scan 1 (at least 2 weeks after initial enrollment); for 850796, fMRI scan 1 (at least 6 weeks after initial enrollment)]]In key neural cue reactivity regions (based on prior work), we will extract estimates of neural activity during exposure to images showing the cash register area at a convenience store which sells tobacco products, and has tobacco products and tobacco marketing on display behind the register (the power wall; tobacco retail images), and during exposure to nonsmoking cues. We used SPM12 to create first-level (within-subject) linear regression models to estimate BOLD (blood oxygenation level dependent) activity at each voxel across all repetitions of each task condition, within each subject; and to create contrast estimates comparing task conditions. We used nilearn tools to average task condition contrast estimates across voxels within the regions of interest for each participant. The data values below reflect this contrast estimate - the difference in neural activity as percent change in BOLD signal between the retail smoking cues condition and the nonsmoking cues condition.

Countries

United States

Participant flow

Recruitment details

Adults who smoked cigarettes daily were recruited across PA, DE, and NJ to complete a multi-part, remote study. Recruitment materials for this study were primarily distributed by a clinical trials recruitment company, which utilized study advertisements to engage participants on digital platforms such as Facebook, Google, and WebMD. All recruitment materials included links directing potential participants to the initial screening survey.

Pre-assignment details

Participants completed several screening steps to confirm eligibility and interest in the study. If eligible, they completed the first online survey session, and then began the baseline period, during which they answered questions about their cigarette craving and smoking multiple times daily and recorded their geolocation through the Google Maps smartphone application. Participants who completed the baseline period and began the intervention period were assigned to an experimental condition.

Participants by arm

ArmCount
Tobacco Retailer Group
Participants visit a tobacco retailer 5 times per week during the 4-week (20 store visits total) intervention period Tobacco retailer: Assigned to make a small (\ $3.00) purchase from a tobacco retail store(s) using a study-provided debit card during each retail environment visit
109
Non-tobacco Retailer Group
Participants visit a non-tobacco retailer 5 times per week during the 4-week (20 store visits total) intervention period Non-tobacco retailer: Assigned to make a small (\ $3.00) purchase from a store that does not sell tobacco (non-tobacco retailer) using a study-provided debit card during each retail environment visit.
109
Control
Participants are not asked to alter their behavior during the 4-week (0 store visits) intervention period
76
Unassigned
Participants who enrolled in the study, but did not complete the baseline period and were therefore not assigned to an experimental condition
49
Total343

Baseline characteristics

CharacteristicTobacco Retailer GroupNon-tobacco Retailer GroupControlUnassignedTotal
Age, Continuous44 years
STANDARD_DEVIATION 11
42 years
STANDARD_DEVIATION 11
42 years
STANDARD_DEVIATION 10
43 years
STANDARD_DEVIATION 11
43 years
STANDARD_DEVIATION 11
Daily cigarette count13.29 cigarettes
STANDARD_DEVIATION 6.35
14.17 cigarettes
STANDARD_DEVIATION 19.18
14.05 cigarettes
STANDARD_DEVIATION 9.84
14.17 cigarettes
STANDARD_DEVIATION 9.18
13.71 cigarettes
STANDARD_DEVIATION 8.71
Daily cigarette craving47.89 units on a scale
STANDARD_DEVIATION 20.7
49.17 units on a scale
STANDARD_DEVIATION 19.61
48.03 units on a scale
STANDARD_DEVIATION 20.81
59.86 units on a scale
STANDARD_DEVIATION 19.42
49.40 units on a scale
STANDARD_DEVIATION 20.43
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants7 Participants3 Participants3 Participants22 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
99 Participants102 Participants71 Participants42 Participants314 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants2 Participants4 Participants7 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
Asian
0 Participants3 Participants3 Participants2 Participants8 Participants
Race (NIH/OMB)
Black or African American
27 Participants24 Participants17 Participants25 Participants93 Participants
Race (NIH/OMB)
More than one race
2 Participants9 Participants4 Participants0 Participants15 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants4 Participants4 Participants5 Participants17 Participants
Race (NIH/OMB)
White
75 Participants69 Participants47 Participants17 Participants208 Participants
Region of Enrollment
United States
109 Participants109 Participants76 Participants49 Participants343 Participants
Sex/Gender, Customized
Sex/gender
Female
59 Participants60 Participants42 Participants20 Participants181 Participants
Sex/Gender, Customized
Sex/gender
Male
46 Participants44 Participants32 Participants25 Participants147 Participants
Sex/Gender, Customized
Sex/gender
Other
3 Participants5 Participants1 Participants0 Participants9 Participants
Sex/Gender, Customized
Sex/gender
Unknown
1 Participants0 Participants1 Participants4 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1090 / 1090 / 760 / 49
other
Total, other adverse events
0 / 1090 / 1090 / 760 / 49
serious
Total, serious adverse events
2 / 1095 / 1090 / 760 / 49

Outcome results

Primary

Brain Activity (Measured by fMRI), in a Priori Regions of Interest, in Response to Retail Smoking vs Nonsmoking Cues

In key neural cue reactivity regions (based on prior work), we will extract estimates of neural activity during exposure to images showing the cash register area at a convenience store which sells tobacco products, and has tobacco products and tobacco marketing on display behind the register (the power wall; tobacco retail images), and during exposure to nonsmoking cues. We used SPM12 to create first-level (within-subject) linear regression models to estimate BOLD (blood oxygenation level dependent) activity at each voxel across all repetitions of each task condition, within each subject; and to create contrast estimates comparing task conditions. We used nilearn tools to average task condition contrast estimates across voxels within the regions of interest for each participant. The data values below reflect this contrast estimate - the difference in neural activity as percent change in BOLD signal between the retail smoking cues condition and the nonsmoking cues condition.

Time frame: [Time Frame: For 822815, fMRI scan 1 (at least 2 weeks after initial enrollment); for 850796, fMRI scan 1 (at least 6 weeks after initial enrollment)]]

Population: Participants who completed at least one scan and whose data passed quality thresholds for in-scanner movement and response rate. Due to COVID-19 pandemic restrictions during data collection, we changed the protocol to make the fMRI scan optional, which means that we do not have adequate statistical power to test experimental group differences. No participants in the unassigned group were scanned, since they did not begin the intervention period.

ArmMeasureValue (MEAN)Dispersion
Tobacco Retailer GroupBrain Activity (Measured by fMRI), in a Priori Regions of Interest, in Response to Retail Smoking vs Nonsmoking Cues0.062 percent change in BOLD signalStandard Deviation 0.118
Non-tobacco Retailer GroupBrain Activity (Measured by fMRI), in a Priori Regions of Interest, in Response to Retail Smoking vs Nonsmoking Cues0.012 percent change in BOLD signalStandard Deviation 0.092
ControlBrain Activity (Measured by fMRI), in a Priori Regions of Interest, in Response to Retail Smoking vs Nonsmoking Cues0.018 percent change in BOLD signalStandard Deviation 0.108
Primary

Brain Activity (Measured by Functional Magnetic Resonance Imaging) in a Priori Regions of Interest, in Response to Standardized Smoking vs Nonsmoking Cues.

In key neural cue reactivity regions (based on prior work), we extracted estimates of neural activity during exposure to standardized smoking cues (e.g., photographs of a cigarette pack) and during exposure to standardized nonsmoking cues (approximately compositionally matched, e.g., a pack of pencils). We used SPM12 to create first-level (within-subject) linear regression models to estimate BOLD (blood oxygenation level dependent) activity at each voxel across all repetitions of each task condition, within each subject; and to create contrast estimates comparing task conditions. We used nilearn tools to average task condition contrast estimates across voxels within the regions of interest for each participant. The data values below reflect this contrast estimate - the difference in neural activity as percent change in BOLD signal between the standardized smoking cues condition and the standardized nonsmoking cues condition.

Time frame: [Time Frame: For 822815, fMRI scan 1 (at least 2 weeks after initial enrollment); for 850796, fMRI scan 1 (at least 6 weeks after initial enrollment)]]

Population: Participants who completed at least one scan and whose data passed quality thresholds for in-scanner movement and response rate. Due to COVID-19 pandemic restrictions during data collection, we changed the protocol to make the fMRI scan optional, which means that we do not have adequate statistical power to test experimental group differences. No participants in the unassigned group were scanned, since they did not begin the intervention period.

ArmMeasureValue (MEAN)Dispersion
Tobacco Retailer GroupBrain Activity (Measured by Functional Magnetic Resonance Imaging) in a Priori Regions of Interest, in Response to Standardized Smoking vs Nonsmoking Cues.0.021 percent change in BOLD signalStandard Deviation 0.089
Non-tobacco Retailer GroupBrain Activity (Measured by Functional Magnetic Resonance Imaging) in a Priori Regions of Interest, in Response to Standardized Smoking vs Nonsmoking Cues.-0.025 percent change in BOLD signalStandard Deviation 0.08
ControlBrain Activity (Measured by Functional Magnetic Resonance Imaging) in a Priori Regions of Interest, in Response to Standardized Smoking vs Nonsmoking Cues.0.035 percent change in BOLD signalStandard Deviation 0.12
Primary

Self-reported Cigarette Craving During the Experimental Manipulation Period

Participants were asked 4 times per day, for the 28 days of the intervention period, to rate their level of craving for a cigarette. They responded to the question Right now, how much do you want to smoke a cigarette? using a 100-point scale from 0 (not at all) to 100 (extremely). Craving ratings were first averaged within each day, for each participant; then were averaged across the intervention period days for each participant; and finally averaged across participants in each group.

Time frame: 4-week experimental manipulation period

Population: All participants who responded to any craving rating questions during the intervention period are included in this average. Participants in the unassigned group did not begin the intervention period and therefore are have no outcome data to report.

ArmMeasureValue (MEAN)Dispersion
Tobacco Retailer GroupSelf-reported Cigarette Craving During the Experimental Manipulation Period48.33 units on a scaleStandard Deviation 25.3
Non-tobacco Retailer GroupSelf-reported Cigarette Craving During the Experimental Manipulation Period49.14 units on a scaleStandard Deviation 22.96
ControlSelf-reported Cigarette Craving During the Experimental Manipulation Period47.17 units on a scaleStandard Deviation 24.24
Comparison: Our hypothesis was that craving would be higher for those in the Tobacco retailer group, relative to the Nontobacco retailer group, during the intervention phase but not the baseline phase. We tested the interaction between study phase and experimental condition, in a model where the baseline was the reference study phase and Tobacco group was the reference experimental condition.p-value: 0.74Mixed Models Analysis
Comparison: Our hypothesis was that craving would be higher for those in the Tobacco retailer group, relative to the control group, during the intervention phase but not the baseline phase. We tested the interaction between study phase and experimental condition, in a model where the baseline was the reference study phase and Tobacco group was the reference experimental condition.p-value: 0.69Mixed Models Analysis
Primary

Self-reported Number of Cigarettes Smoked Per Day During the Experimental Manipulation Period

Participants were asked 2 times per day, for the 28 days of the intervention period, to respond to the question, Within \[timeframe\], how many cigarettes did you smoke?. We calculated a daily sum for each individual, imputing missing counts from the average of that individual's prior reports (missing values for the first daily survey were imputed from the average of that participant's first daily survey answers; and vice versa for the second survey). We averaged the daily counts for each participant, and then averaged across participants.

Time frame: 4-week experimental manipulation period

Population: All participants who responded to any cigarette consumption questions during the intervention period are included in this average. Participants in the unassigned group did not begin the intervention period and therefore are have no outcome data to report.

ArmMeasureValue (MEAN)Dispersion
Tobacco Retailer GroupSelf-reported Number of Cigarettes Smoked Per Day During the Experimental Manipulation Period12.72 cigarettesStandard Deviation 6.26
Non-tobacco Retailer GroupSelf-reported Number of Cigarettes Smoked Per Day During the Experimental Manipulation Period12.88 cigarettesStandard Deviation 8.27
ControlSelf-reported Number of Cigarettes Smoked Per Day During the Experimental Manipulation Period13.64 cigarettesStandard Deviation 7.55
Comparison: Our hypothesis was that cigarettes smoked would be higher for those in the Tobacco retailer group, relative to the Nontobacco retailer group, during the intervention phase but not the baseline phase. We tested the interaction between study phase and experimental condition, in a model where the baseline was the reference study phase and Tobacco group was the reference experimental condition.p-value: 0.49Mixed Models Analysis
Comparison: Our hypothesis was that craving would be higher for those in the Tobacco retailer group, relative to the control group, during the intervention phase but not the baseline phase. We tested the interaction between study phase and experimental condition, in a model where the baseline was the reference study phase and Tobacco group was the reference experimental condition.p-value: 0.72Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026